METHYLERGONOVINE MALEATE
Clinical safety rating: avoid
Positive evidence of fetus risks but benefits may outweigh risks in some cases
Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.
Tablet 0.2 mg - Oral
Clinical note
Strong CYP3A4 inhibitors are contraindicated due to risk of ergotism Contraindicated in hypertension and coronary artery disease.
vomiting
Loading safety data…
